Your browser doesn't support javascript.
loading
A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis.
Smith, Jennifer; McDaid, John P; Bhangal, Gurjeet; Chawanasuntorapoj, Ratana; Masuda, Esteban S; Cook, H Terence; Pusey, Charles D; Tam, Frederick W K.
Affiliation
  • Smith J; Imperial College Kidney and Transplant Institute, Division of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom.
J Am Soc Nephrol ; 21(2): 231-6, 2010 Feb.
Article in En | MEDLINE | ID: mdl-19959716

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxazines / Pyridines / Severity of Illness Index / Protein-Tyrosine Kinases / Intracellular Signaling Peptides and Proteins / Glomerulonephritis Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2010 Document type: Article Affiliation country: United kingdom Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxazines / Pyridines / Severity of Illness Index / Protein-Tyrosine Kinases / Intracellular Signaling Peptides and Proteins / Glomerulonephritis Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2010 Document type: Article Affiliation country: United kingdom Country of publication: United States